The National Cancer Research Institute (NCRI), of which Brain Tumour Research is a proud partner, has published a report outlining key points from the Beyond the Horizon: ‘Innovative cancer drug discovery’ event.

The aim of the report is to galvanise players across the cancer research landscape to reimagine current drug discovery efforts.

Beyond the Horizon is an NCRI led initiative to define the current and future challenges and the transformational changes needed across cancer research.

The first Beyond the Horizon virtual event, ‘Innovative cancer drug discovery’, brought together expert panelists and more than 300 delegates from across the research community. In a series of open and insightful panel sessions, broad solutions needed to transform modern drug discovery efforts were discussed.

The summary report brings together key questions and insights from the event discussions, stakeholder consultations and audience questions and follow-up comments, which converge into four cross-cutting themes:

• A stronger biological understanding
• Technology as an enabler of better research
• Cross-boundary collaboration
• Bridging the translational gap

You can read the report online here: www.ncri.org.uk/reimagining-drug-discovery-report/

Related reading:

• The cost of developing new treatments and the case for front-loading discovery science funding

If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.